Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Global Nanoparticles in Biology and Medicine Market 2021
Nanomaterials are at the leading edge of the rapidly developing field of nanotechnology with many potential applications in biology and medicine research. Nanomaterials offer great possibilities for biomedical applications because of their high flexibility, stability, modular character, and biocompatibility. The global nanoparticles in biology and medicine market in terms of revenue is set to grow by US$ 39 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period, according to data and analytics company StrategyHelix.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for nanoparticles in biology and medicine. The global nanoparticles in biology and medicine market is segmented on the basis of type, region. By type, it is categorized into biotechnology, drug development & formulation, and drug delivery systems. The drug delivery systems segment held the largest market share in 2020. However, the drug development & formulation segment is expected to witness the highest CAGR during the forecast period. By region, the nanoparticles in biology and medicine market is divided into North America, Asia Pacific, Europe, and Rest of the World (ROW). In 2020, the North America region held the largest share of the market, and the Asia Pacific region is anticipated to register the highest CAGR during 2021 to 2027.
The report has profiled some of the key players of the market such as Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck KGaA, NanoCarrier Co. Ltd., Novartis AG.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the nanoparticles in biology and medicine market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Type: biotechnology, drug development & formulation, and drug delivery systems
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global nanoparticles in biology and medicine market
Pinpoint growth sectors and trends for investment
Understand what the future of the global nanoparticles in biology and medicine market looks like
Identify the competitive landscape and window of opportunity
Table of Contents
1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. Nanoparticles in Biology and Medicine Market by Type
4.2 Drug Development & Formulation
4.3 Drug Delivery Systems
5. Nanoparticles in Biology and Medicine Market by Region
5.1 North America
5.2 Asia Pacific
5.4 Rest Of The World (Row)
6. Company Profiles
6.1 Bristol-Myers Squibb Company
6.2 F. Hoffmann-La Roche Ltd.
6.3 GlaxoSmithKline plc
6.4 Merck KGaA
6.5 NanoCarrier Co., Ltd.
6.6 Novartis AG
7.1 About StrategyHelix
1 May 2021